Transforming Lives: The Impact of Weight-Loss Drugs in Hong Kong
Kathryn Dean successfully used GLP-1 agonist drugs semaglutide and tirzepatide to lose 18 kg, shedding her prediabetes diagnosis. Research indicates a rising diabetes trend in Hong Kong, with many suffering …
Transforming Lives: The Impact of Weight-Loss Drugs in Hong Kong Read More